reviewTop 1% cited

Pharmacodynamics, Efficacy and Safety of Sodium–Glucose Co-Transporter Type 2 (SGLT2) Inhibitors for the Treatment of Type 2 Diabetes Mellitus

Drugs · 2014 · Vol. 75(1) · pp. 33–59

André Scheen✉(University of Liège)

Diabetes Treatment and Management Pharmacology and Obesity Treatment Chronic Kidney Disease and DiabetesEmpagliflozinDapagliflozinMedicineCanagliflozinRenal glucose reabsorptionMetforminSitagliptinPharmacologyType 2 diabetesType 2 Diabetes Mellitus

MeSH terms

CanagliflozinSodium-Glucose Transporter 2 InhibitorsBenzhydryl CompoundsDiabetes Mellitus, Type 2GlucosidesHumansHypoglycemic AgentsThiophenesSodium-Glucose Transporter 2

Citations

555

FWCI

28.53

field-weighted impact

References

158

Percentile

100%

vs. same field & year

Citations per year

Cited by

Type II diabetes mellitus: a review on recent drug based therapeutics

Biomedicine & Pharmacotherapy · 2020 · 680 citations

References

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Diabetologia · 2012 · 3,930 citations

Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.